Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Six Brokers Cut Tate & Lyle Price Target

Fri, 14th Feb 2014 10:10

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
JPMORGAN RAISES LLOYDS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 95 (84) PENCE
----------
SOCGEN RAISES LLOYDS PRICE TARGET TO 94 (86) PENCE - 'BUY'
----------
BERENBERG RAISES PETROFAC TO 'BUY' ('HOLD') - TARGET 1740 (1370) PENCE
----------
BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1545) PENCE - 'EQUAL WEIGHT'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1800 (1750) PENCE - 'HOLD'
----------
EXANE BNP CUTS MORRISON TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 200 (230) PENCE
----------
SOCGEN RAISES ROLLS-ROYCE TO 'HOLD' ('SELL') - TARGET 1070 (1150) PENCE
----------
LIBERUM CUTS ROLLS-ROYCE PRICE TARGET TO 1300 (1340) PENCE - 'BUY'
----------
JPMORGAN CUTS TATE & LYLE PRICE TARGET TO 825 (900) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS TATE & LYLE PRICE TARGET TO 800 (900) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS TATE & LYLE PRICE TARGET TO 900 (1030) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS TATE & LYLE PRICE TARGET TO 700 (800) PENCE - 'NEUTRAL'
----------
PANMURE CUTS TATE & LYLE PRICE TARGET TO 680 (750) PENCE - 'HOLD'
----------
MORGAN STANLEY CUTS TATE & LYLE PRICE TARGET TO 700 (880) PENCE - 'EQUAL-WEIGHT'
----------
CITIGROUP RAISES RIO TINTO PRICE TARGET TO 4200 (4000) PENCE - 'BUY'
----------
JPMORGAN RAISES RIO TINTO PRICE TARGET TO 4600 (4500) PENCE - 'OVERWEIGHT'
----------
MERRILL LYNCH CUTS RIO TINTO TO 'NEUTRAL' ('BUY') - PRICE TARGET 3800 (4200) PENCE
----------
EXANE BNP CUTS RECKITT BENCKISER PRICE TARGET TO 4400 (4600) PENCE - 'UNDERPERFORM,'
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3870 (3615) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES SHIRE PRICE TARGET TO 3400 (3200) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE CUTS BARCLAYS PRICE TARGET TO 260 (270) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES AGGREKO PRICE TARGET TO 1300 (1250) PENCE - 'UNDERWEIGHT'
----------
MORGAN STANLEY RAISES BABCOCK INTERNATIONAL PT TO 1550 (1450) PENCE - 'OVERWEIGHT.'
----------
MORGAN STANLEY RAISES BRITISH LAND PRICE TARGET TO 750 (690) PENCE - 'OVERWEIGHT.'
----------
MORGAN STANLEY RAISES HAMMERSON PT TO 560 (540) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES LAND SECURITIES PT TO 1120 (1040) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS INTERTEK PRICE TARGET TO 3300 (3750) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS RAISES LADBROKES TO 'BUY' ('NEUTRAL') - TARGET 180 PENCE
----------
JPMORGAN RAISES ENTERTAINMENT ONE PRICE TARGET TO 356 (280) PENCE - 'OVERWEIGHT.'
----------
JPMORGAN RAISES MORGAN ADVANCED MATERIALS PRICE TARGET TO 350 (330) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS OPHIR ENERGY PRICE TARGET TO 400 (440) PENCE - 'OVERWEIGHT'
----------
MERRILL LYNCH CUTS TELECITY GROUP PRICE TARGET TO 595 (650) PENCE - 'UNDERPERFORM'
----------
UBS CUTS TELECITY GROUP PRICE TARGET TO 825 (950) PENCE - 'BUY'
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 1750 (1850) PENCE - 'BUY'
----------
UBS CUTS SERCO PRICE TARGET TO 400 (505) PENCE - 'NEUTRAL'
----------
UBS RAISES BELLWAY PRICE TARGET TO 1930 (1875) PENCE - 'BUY'
----------
PANMURE RAISES BELLWAY PRICE TARGET TO 1639 (1520) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 826 (822) PENCE - 'HOLD'
----------
PANMURE RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1375 (1350) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES CARILLION PRICE TARGET TO 325 (315) PENCE - EQUAL-WEIGHT
----------
MORGAN STANLEY RAISES CAPITA GROUP PRICE TARGET TO 1050 (1000) PENCE - 'EQUAL-WEIGHT'
----------
PANMURE CUTS PZ CUSSONS PRICE TARGET TO 430 (445) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES DERWENT LONDON PRICE TARGET TO 3100 (2900) PENCE - OVERWEIGHT.
----------
MORGAN STANLEY RAISES GREAT PORTLAND PRICE TARGET TO 730 (680) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY RAISES INTU PROPERTIES PRICE TARGET TO 310 (300) PENCE - 'UNDERWEIGHT'
----------
MORGAN STANLEY RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 135 (127) PENCE - 'UNDERW.'
----------
MORGAN STANLEY RAISES SEGRO PLC PRICE TARGET TO 380 (345) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS SHAFTESBURY PRICE TARGET TO 660 (680) PENCE - 'EQUAL-WEIGHT.'
----------
NUMIS RAISES DE LA RUE TO 'ADD' ('HOLD') - TARGET 854 PENCE
----------
ALL-SHARE AND AIM
----------
MORGAN STANLEY CUTS APR ENERGY PRICE TARGET TO 1350 (1400) PENCE - 'OVERWEIGHT'
----------
PANMURE CUTS PHOENIX IT PRICE TARGET TO 138 (141) PENCE - 'HOLD'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.